Botulinum toxin therapy in children with neurogenic detrusor overactivity [PDF]
Urology Research and Practice, 2019 Special birth defects and neurological diseases can cause neurogenic detrusor overactivity (NDO). First-line pharmacotherapy is the antimuscarinic therapy, which can be limited by side effects or non-effectiveness. Therefore, pharmacological treatment of
Jasmin Katrin Badawi
doaj +5 more sources
Clinical Outcomes of Botulinum Toxin A Management for Neurogenic Detrusor Overactivity: Meta-Analysis [PDF]
Renal Failure, 2019 The aim of this work was to evaluate the efficacy and safety of botulinum toxin A (BTX-A) treatment in patients with neurogenic detrusor overactivity.
Zheng-Yan Gao, Feng Zhao
exaly +3 more sources
Effects of repetitive functional magnetic stimulation in the sacral nerve in patients with neurogenic detrusor overactivity after suprasacral spinal cord injury: a study protocol for a randomized controlled trial [PDF]
Trials, 2023 Background Neurogenic detrusor overactivity (NDO) is a serious and common complication after spinal cord injury, affecting patients’ quality of life seriously.
Jiyang Li +9 more
doaj +2 more sources
Efficacy and Predictive Factors of Intravesical Botulinum Toxin A Injection for Treating Neurogenic Detrusor Overactivity in Children: A Single-Center Retrospective Study [PDF]
ToxinsNeurogenic detrusor overactivity (NDO) is a complex condition associated with detrusor overactivity, reduced bladder compliance, and high intravesical pressures, potentially leading to urinary tract infections (UTIs) and renal impairment.
Chun-Kai Hsu +4 more
doaj +2 more sources
Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report [PDF]
Journal of Medical Case Reports, 2021 Background Myelomeningocele, which causes a neurogenic bladder, is usually treated with anticholinergics in children with neurogenic detrusor overactivity (NDO); however, anticholinergics cause side effects such as dry mouth, constipation, attention ...
Taiki Kato +4 more
doaj +2 more sources
Review of combined intravesical and urethral botulinum neurotoxin type A injection in patients with neurogenic lower urinary tract dysfunction [PDF]
Tzu Chi Medical JournalNeurogenic lower urinary tract dysfunction (NLUTD) is frequently characterized by coexisting storage and voiding abnormalities, particularly in patients with spinal cord injury (SCI) and concomitant detrusor overactivity (DO) and detrusor sphincter ...
Hsiu-Hsun Liu +3 more
doaj +2 more sources
Urology Research and Practice, 2023 Objective: Urodynamics of the storage phase showing detrusor overactivity is com- mon in neurogenic bladder patients. Terminal detrusor overactivity, which is defined by involuntary detrusor contraction that cannot be inhibited, causes urinary incon ...
Takeya Kitta +9 more
doaj +1 more source
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis [PDF]
Investigative and Clinical Urology, 2020 After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB ...
Jing-Liang Chen , Hann-Chorng Kuo
doaj +1 more source
Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis [PDF]
International Neurourology Journal, 2017 Purpose OnabotulinumtoxinA is used widely for the treatment of neurogenic detrusor overactivity. We conducted a systematic review and meta-analysis to assess its efficacy and safety for neurogenic detrusor overactivity treatment.
Hejia Yuan +5 more
doaj +1 more source
Journal of Rehabilitation Medicine, 2022 Objective: To investigate the effects of concomitant injections of botulinum toxin-A (BoNT-A) into the detrusor and external urethral sphincter muscles in suprasacral spinal cord injured patients with detrusor overactivity and detrusor sphincter ...
Yu-Hui Huang, Sung-Lang Chen
doaj +1 more source